New study aims to spot cancer early in NF1 patients
NCT ID NCT02211768
First seen Oct 31, 2025 · Last updated May 15, 2026 · Updated 35 times
Summary
This study looked at 10 people with neurofibromatosis type 1 (NF1) to understand how benign tumors (plexiform neurofibromas) turn into a rare cancer called MPNST. Researchers used advanced scans and genetic testing to find better ways to detect cancer early. The goal was to improve diagnosis, not to test a treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROFIBROMATOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.